Leidos beat its own guidance by a wide margin through 2023 and 2024, then hit a real speed bump in early 2025 when new bookings collapsed under a new presidential administration — responding not with silence but with a brand-new five-year strategy and a full rebrand of its government-facing language.
The story
2023–2024: the honor-roll years
In Q3 2023, Leidos raised full-year guidance across every metric, citing a strong quarter, and finished the year above even that raised range. The pattern repeated through 2024: CEO Thomas Bell opened the year calling it a "thrilled" start and raised guidance three more times over the following quarters. The initial FY2024 revenue guidance had been $15.7–16.1B (2–4% growth); actual revenue came in at $16.66B (+7.9%), more than $500M above the top of that original range. The same quarter delivered the highest December-quarter book-to-bill in the company's history, at 1.7x.
Q1 2025: the streak breaks — not with a miss, but with a pause
Then, in May 2025, something different happened. Results were still strong — annualized EPS guidance implied a run rate roughly 10% above the top end — but instead of raising 2025 guidance again, management said only that it would "reaffirm" it. New bookings (book-to-bill) fell to 0.5x, the lowest of the twelve quarters reviewed. Analyst Scott Mikus asked CFO Chris Cage directly: given the reaffirmed guidance and the drop in book-to-bill, was this a sign of real fundamental weakening, or just extreme conservatism tied to the new administration's executive orders and DOGE (the Department of Government Efficiency)? Cage acknowledged there was "nothing wrong with the fundamentals," but conceded, "now is not the time to raise guidance."
The response: a new strategy, not a defensive posture
Leidos's response was telling. Rather than defend the guidance language, it used that same quarter to unveil a brand-new five-year growth strategy, "NorthStar 2030," explicitly stating it would "proactively align with the new administration's priorities." The filings shifted too: the FY2025 10-K replaced "Department of Defense (DoD)" with "Department of War (DoW)" — the name the new administration actually adopted — and added a new risk factor, "Prioritizing the Warfighter in Defense Contracting," an executive order that appeared in four separate risk-factor sections. Starting in 2026, the company also announced it would fully restructure its four segments into Intelligence & Digital, Health, Homeland, and Defense, with the new names first appearing in Q1 FY2026 reporting. Headcount, which had grown for three straight years (43,000 to 48,000), fell for the first time in FY2025, to 47,000.
Where it stands now
The recovery was steady rather than dramatic. Book-to-bill climbed back to 0.9x in Q2 FY2025, then held at 1.3x for two straight quarters (Q3, Q4). Full-year 2025 revenue of $17.17B landed squarely inside the original $16.9–17.3B guidance range — a return to precision rather than the outsized beats of 2024. By 2026, with the Entrust acquisition ($2.4B) layered on, guidance was raised twice more, and management said on the Q2 FY2026 call that "NorthStar 2030 and the resilience of our portfolio" allowed another raise — confidence language that had been notably absent a year earlier.
Guidance vs. actual results
| Fiscal year | Initial guidance | Actual | Result |
|---|---|---|---|
| FY2024 | $15.7–16.1B (+2–4%) | $16.66B (+7.9%) | Beat by $560M above the top |
| FY2025 | $16.9–17.3B (up to +4%) | $17.17B | Landed squarely in range |
| FY2026 | $17.5–17.9B, raised twice to $18.0–18.4B+ | In progress | Raised twice so far |
Source: Q4 FY2023, Q4 FY2024, and Q4 FY2025 earnings calls (initial guidance); 10-K FY2024 and FY2025 (actuals); Q1–Q2 FY2026 earnings calls.
The pattern shifted between years, not just in outcome: FY2024 was "beat the guidance by a wide margin," while FY2025 was "land exactly inside the guidance" — a change that can be read either as sharper forecasting or as reduced upside room, or both.
Timeline
- Oct. 2023–Oct. 2024Five consecutive quarters of guidance raises. FY2024 actual revenue beats initial guidance by more than $500M.
- Feb. 2025FY2025 10-K still discloses an ongoing DOJ antitrust grand-jury investigation opened in August 2022, unresolved for over three years.
- May 2025Q1 FY2025 call: guidance is "reaffirmed," not raised, for the first time; book-to-bill drops to 0.5x. "NorthStar 2030" strategy unveiled the same call.
- Aug.–Nov. 2025Book-to-bill recovers to 0.9x, then 1.3x for two straight quarters; key program renewals (including MHS GENESIS) secured.
- Jan.–Feb. 2026Entrust acquisition ($2.4B) announced; four-segment reorganization into Intelligence & Digital, Health, Homeland, and Defense disclosed in the 10-K.
- May–Aug. 2026Guidance raised in two consecutive quarters; record quarterly free cash flow reported in Q2 FY2026.
Our read
The single "reaffirm" and the 0.5x book-to-bill in early 2025 weren't noise — they were a real-time demonstration that a change in presidential administration can hit a government contractor's new-order pipeline directly, even while revenue and earnings hold up. Leidos absorbed the shock numerically almost immediately (EPS still beat guidance that same quarter) but reacted verbally and strategically much faster and more visibly — new guidance language, a new five-year strategy, and new segment and department names. Whether NorthStar 2030 becomes more than a name change depends on how the newly reorganized Homeland and Defense segments perform through 2026.
What we still don't know
- How profitability shifts under the four newly reorganized segments (Intelligence & Digital, Health, Homeland, Defense) won't be clear until full-year 2026 results are in.
- Why the 2022 DOJ antitrust grand-jury investigation remains unresolved after three-plus years, and what risk it still carries, isn't disclosed in enough detail here.
- Whether Q1 2025's book-to-bill drop to 0.5x was Leidos-specific or an industry-wide reaction to the new administration would require comparing peer government contractors' results from the same quarter.
- How margins and leverage look once the $2.4B Entrust acquisition is fully integrated needs confirmation from 2026's second-half and later filings.
Frequently asked questions
What happened to Leidos' guidance in early 2025?
After five straight quarters of raising guidance, Leidos only “reaffirmed” its 2025 outlook in May 2025, and new bookings (book-to-bill) dropped to 0.5x — the lowest of the twelve quarters reviewed — coinciding with a change in presidential administration.
How did Leidos respond to that slowdown?
In the same quarter, it unveiled a new five-year strategy called “NorthStar 2030,” updated its filings to reference the “Department of War” rather than the “Department of Defense,” and later restructured its four business segments entirely.
What sources does this analysis draw from?
This piece is built from Leidos' 10-K filings for fiscal years 2021 through 2025 and twelve quarters of earnings-call transcripts spanning Q3 FY2023 through Q2 FY2026.